Table 7.
Biologic and anthropometric characteristics in the general population by insulin resistance status (Maracaibo, Venezuela, 2015).
HOMA2-IR < 2 (n = 1083) | HOMA2-IR ≥ 2 (n = 943) | p ∗ | |
---|---|---|---|
Age (years)a | 38.48 ± 15.50 | 41.09 ± 15.11 | 3.15 × 10−5 |
Body Mass Index (kg/m2)a | 26.39 ± 5.24 | 30.60 ± 6.52 | 7.13 × 10−55 |
Waist circumference (cm)a | 89.92 ± 12.68 | 100.34 ± 16.6 | 4.49 × 10−54 |
Fasting glycemia (mg/dL)a | 91.88 ± 20.99 | 107.48 ± 50.78 | 3.41 × 10−39 |
Fasting insulin (µU/mL)a | 8.80 ± 2.70 | 21.46 ± 10.15 | <0.001 |
HOMA2-IRa | 1.31 ± 0.40 | 3.24 ± 1.47 | <0.001 |
Total cholesterol (mg/dL)a | 186.91 ± 45.67 | 196.87 ± 46.31 | 2.39 × 10−7 |
Triacylglycerides (mg/dL)a | 110.70 ± 76.27 | 154.48 ± 122.02 | 5.45 × 10−29 |
LDL-C (mg/dL)a | 118.80 ± 38.06 | 125.25 ± 38.84 | <0.001 |
HDL-C (mg/dL)a | 45.90 ± 12.58 | 41.97 ± 10.95 | 3.67 × 10−14 |
Systolic BP (mmHg)a | 117.91 ± 16.57 | 121.96 ± 17.08 | 2.33 × 10−8 |
Diastolic BP (mmHg)a | 75.75 ± 10.99 | 79.05 ± 11.44 | 2.93 × 10−11 |
hs-CRP (mg/dL)b | 0.313 (0.086–0.622) | 0.420 (0.154–0.942) | 4.51 × 10−7 |
LDL-C: low-density lipoprotein-cholesterol; HDL-C: high-density lipoprotein-cholesterol; BP: blood pressure; hs-CRP: High-Sensitivity C-Reactive Protein.
aNormally distributed variable, expressed as mean ± standard deviation; bnonnormally distributed variable, expressed as median (25th percentile–75th percentile).
∗Student's t-test was used for normally distributed variables; Mann-Whitney U test was used for nonnormally distributed variables.